Evidence map›Paper›PMID 36769579›Full record

ArticleJournal of clinical medicine2023

Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning.

Rubén Queiro, Daniel Seoane-Mato, Ana Laiz, Eva Galindez Agirregoikoa, Carlos Montilla, Hye S Park, Jose A Pinto Tasende, Juan J Bethencourt Baute, Beatriz Joven Ibáñez, Elide Toniolo and 5 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rubén QueiroRheumatology Service & the Principality of Asturias Institute for Health Research (ISPA), Faculty of Medicine, Universidad de Oviedo, 33006 Oviedo, Spain.ORCID 0000-0002-8418-7145
Daniel Seoane-MatoResearch Unit, Spanish Society of Rheumatology, 28001 Madrid, Spain.ORCID 0000-0001-5430-039X
Ana LaizRheumatology and Autoimmune Disease Department, Hospital Universitari de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.ORCID 0000-0002-2820-4801
Eva Galindez AgirregoikoaRheumatology Service, Hospital Universitario Basurto, 48013 Bilbao, Spain.
Carlos MontillaRheumatology Service, Hospital Universitario de Salamanca, 37007 Salamanca, Spain.
Hye S ParkRheumatology and Autoimmune Disease Department, Hospital Universitari de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.ORCID 0000-0002-4972-9527
Jose A Pinto TasendeRheumatology Service-INIBIC, Complexo Hospitalario Universitario de A Coruña, 15006 A Coruña, Spain.ORCID 0000-0002-4993-8185
Juan J Bethencourt BauteRheumatology Service, Hospital Universitario de Canarias, 38320 Sta. Cruz de Tenerife, Spain.ORCID 0000-0002-9382-9234
Beatriz Joven IbáñezRheumatology Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Elide TonioloRheumatology Service, Hospital Universitari Son Llàtzer, 07198 Palma de Mallorca, Spain.
Julio RamírezArthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, 08036 Barcelona, Spain.
Nuria MonteroResearch Unit, Spanish Society of Rheumatology, 28001 Madrid, Spain.
Cristina Pruenza García-HinojosaKnowledge Engineering Institute, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Ana Serrano GarcíaKnowledge Engineering Institute, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
On Behalf Of The Proyecto Reapser Study

Funding

AbbVie (Spain) N/A
6 · The paper itself

Abstract

The aim was to identify patient- and disease-related characteristics predicting moderate-to-high disease activity in recent-onset psoriatic arthritis (PsA). We performed a multicenter observational prospective study (2-year follow-up, regular annual visits) in patients aged ≥18 years who fulfilled the CASPAR criteria and had less than 2 years since the onset of symptoms. The moderate-to-high activity of PsA was defined as DAPSA > 14. We trained a logistic regression model and random forest-type and XGBoost machine learning algorithms to analyze the association between the outcome measure and the variables selected in the bivariate analysis. The sample comprised 158 patients. At the first follow-up visit, 20.8% of the patients who attended the clinic had a moderate-to-severe disease. This percentage rose to 21.2% on the second visit. The variables predicting moderate-high activity were the PsAID score, tender joint count, level of physical activity, and sex. The mean values of the measures of validity of the machine learning algorithms were all high, especially sensitivity (98%; 95% CI: 86.89-100.00). PsAID was the most important variable in the prediction algorithms, reinforcing the convenience of its inclusion in daily clinical practice. Strategies that focus on the needs of women with PsA should be considered.

Indexed as

arthritisDAPSAdisease activitymachine learningpredictive modelPsAIDpsoriatic

Identifiers

PMID36769579
PMCPMC9917876

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.